{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:50:10Z","timestamp":1790686210597,"version":"4.1.0"},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.1001\/jamaoncol.2021.0210","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T15:01:10Z","timestamp":1616079670000},"page":"775","source":"Crossref","is-referenced-by-count":26,"title":["Association Between Antiangiogenic Drugs Used for Cancer Treatment and Artery Dissections or Aneurysms"],"prefix":"10.1001","volume":"7","author":[{"given":"Joris","family":"Guyon","sequence":"first","affiliation":[{"name":"Angiogenesis and Cancer Microenvironment Laboratory, Univ. Bordeaux, Inserm U1029, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Gouverneur","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Bordeaux University Hospital, Univ. Bordeaux, Inserm U1219, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Maumus-Robert","sequence":"additional","affiliation":[{"name":"Univ. Bordeaux, Inserm U1219, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"B\u00e9rard","sequence":"additional","affiliation":[{"name":"Unit of Vascular Surgery, Bordeaux University Hospital, Univ. Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Bordeaux University Hospital, Univ. Bordeaux, Inserm U1219, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bikfalvi","sequence":"additional","affiliation":[{"name":"Angiogenesis and Cancer Microenvironment Laboratory, Univ. Bordeaux, Inserm U1029, Pessac, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernelle","family":"Noize","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Bordeaux University Hospital, Univ. Bordeaux, Inserm U1219, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"cld210002r1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1161\/CIRCULATIONAHA.116.025144","article-title":"Association between aortic dissection and systemic exposure of vascular endothelial growth factor pathway inhibitors in the Japanese Adverse Drug Event Report database.","volume":"135","author":"Oshima","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"cld210002r2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/(ISSN)1099-1557","article-title":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.","volume":"11","author":"van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"cld210002r3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/annonc\/mdm550","article-title":"Blood pressure rise following angiogenesis inhibition by bevacizumab. a crucial role for microcirculation.","volume":"19","author":"Mourad","year":"2008","journal-title":"Ann Oncol"},{"issue":"10","key":"cld210002r4","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1161\/01.CIR.91.10.2669","article-title":"Effect of vasa vasorum flow on structure and function of the aorta in experimental animals.","volume":"91","author":"Stefanadis","year":"1995","journal-title":"Circulation"},{"issue":"6","key":"cld210002r5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrc2152","article-title":"Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition.","volume":"7","author":"Verheul","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"cld210002r6","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2018.12.012","article-title":"Short-term risk of aortoiliac aneurysm or dissection associated with fluoroquinolone use.","volume":"73","author":"Maumus-Robert","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"cld210002r7","unstructured":"European Medicines Agency. Pharmacovigilance risk assessment committee (PRAC): 8-11 July 2019. December 19, 2019. Accessed February 16, 2021. https:\/\/www.ema.europa.eu\/en\/events\/pharmacovigilance-risk-assessment-committee-prac-8-11-july-2019"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2777345\/jamaoncology_guyon_2021_ld_210002_1621005043.12418.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T15:09:03Z","timestamp":1621523343000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2777345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.0210","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}